Using Real-Wold Data to Tackle Migraine Care Gaps

Although migraines affect 12% of people in Europe, millions suffer with poor migraine management. Eli Lilly’s OVERCOME (EU) study used real-world data (RWD) from over 20,000 people in Germany and Spain who live with migraine. Just over 40% had not received a formal diagnosis, and most patients who would be eligible for treatment had not used any. As a result, Lilly points out in a recent sponsored article that a European Migrain Action Plan could help address this care gap.

According to the article, the plan consists of, “

1. Increasing public understanding and awareness of migraine
2. Enhancing education on migraine for all healthcare professionals
3. Ensuring appropriate funding for, and access to, high-quality migraine care
4. Implementing efficient care pathways to address patient needs in a timely way
5. Improving work-related outcomes for people with migraine”

To read more, click here.

(Source: Euractiv, July 18th, 2022)